Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ariadne.ai is a Swiss-based contract research organization (CRO) specializing in high-throughput image analysis and biomedical data interpretation for the life sciences industry. The company leverages advanced artificial intelligence and deep learning algorithms to provide automated solutions for large-scale microscopy data, including 3D electron microscopy and light microscopy. Their services are primarily utilized in neurobiology, oncology, and pathology to accelerate drug discovery and preclinical research by quantifying complex cellular structures and biomarkers. Ariadne.ai is recognized for its ability to handle massive datasets with high precision, offering scalable solutions that bridge the gap between raw imaging data and actionable biological insights.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ariadne.